VDA 1275
Alternative Names: VDA-1275Latest Information Update: 25 Sep 2024
At a glance
- Originator VidacPharma
- Class Antineoplastics; Small molecules
- Mechanism of Action Hexokinase inhibitors; Voltage-dependent anion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours